AXA Investment Managers
Linden Thomson, CFA, currently serves as a Senior Fund Manager for the Biotechnology and Oncology Funds at Candriam since February 2024. Previously, Linden was with AXA Investment Managers from June 2011, overseeing the AXA IM Framlington Biotech Fund, which grew over tenfold to approximately £500 million in assets under management, and held roles as Head of the Healthcare Franchise and a member of the UK Executive Committee. Prior to AXA, Linden was a Junior Partner at Clear River Capital LLP, contributing to fund setup and investment decisions during the global financial crisis, and started the career as an Analyst/Associate at Goldman Sachs, focusing on biotech within the Global Investment Research team. Linden holds a Bachelor of Science with Honors in Medical Microbiology from The University of Edinburgh.
This person is not in any teams
This person is not in any offices
AXA Investment Managers
20 followers
AXA Investment Managers (AXA IM) is a responsible asset manager, actively investing for the long-term to help its clients, its people and the world to prosper. The AXA Group operates primarily in Western Europe, North America, the Asia Pacific region, and the Middle East, with a presence also in Africa.